Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study

NCT02767219 is registered in ClinicalTrials.gov with Moorfields Eye Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02767219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02767219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study
Lead sponsor
Moorfields Eye Hospital NHS Foundation Trust
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2016
Completion date
May 31, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma